Tag: Prescription Drugs
ICER: New Cholesterol Drugs Highly Overpriced
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia
Responses for patients with myelofibrosis, essential thrombocythemia
Daily PrEP Prevents HIV Infection in High-Risk Individuals
Study participants were infected with other sexually transmitted diseases
Finerenone Linked to Improved UACR in Diabetic Nephropathy
Addition of finerenone to ACE inhibitor or ARB tied to reduction in urinary albumin-creatinine ratio
Study Compares Hospitalized Infection Risk for Biologics in RA
Risk of hospitalized infection increased with etanercept, infliximab, rituximab versus abatacept
Benznidazole Tx Explored in Chagas’ Cardiomyopathy
Reduces serum parasite detection but does not reduce cardiac clinical deterioration through 5 years
Bivalirudin Doesn’t Lower Major Cardiovascular Event Rate in ACS
No decrease in rate of major CV events, net adverse clinical events for patients undergoing PCI
Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use
High risk for zoledronate, denosumab mainly in prevention of skeletal-related events
Intravenous Cyclosporine Doesn’t Improve STEMI Outcomes
For patients undergoing PCI, cyclosporine doesn't prevent adverse left ventricular remodeling at 1 year
Lower Risk of Dabigatran-Tied Bleeding With Gastroprotection
Concomitant use of gastroprotective agents linked to lower risk of gastrointestinal bleeding
